102 related articles for article (PubMed ID: 2739903)
1. Protection by serine peptidase inhibitors of endogenous cholecystokinin released from brain slices.
Rose C; Camus A; Schwartz JC
Neuroscience; 1989; 29(3):583-94. PubMed ID: 2739903
[TBL] [Abstract][Full Text] [Related]
2. Role of a serine endopeptidase in the hydrolysis of exogenous cholecystokinin by brain slices.
Camus A; Rose C; Schwartz JC
Neuroscience; 1989; 29(3):595-602. PubMed ID: 2662053
[TBL] [Abstract][Full Text] [Related]
3. A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brain.
Rose C; Camus A; Schwartz JC
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8326-30. PubMed ID: 3186727
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the role of "enkephalinase" in cholecystokinin inactivation.
Zuzel KA; Rose C; Schwartz JC
Neuroscience; 1985 May; 15(1):149-58. PubMed ID: 3892359
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a serine peptidase responsible for the inactivation of endogenous cholecystokinin in human brain.
Rose C; Vargas F; Silhouette B; Devaux B; Schwartz JC
Neuropeptides; 1995 Mar; 28(3):157-60. PubMed ID: 7791959
[TBL] [Abstract][Full Text] [Related]
6. Immunolocalization of tripeptidyl peptidase II, a cholecystokinin-inactivating enzyme, in rat brain.
Facchinetti P; Rose C; Rostaing P; Triller A; Schwartz JC
Neuroscience; 1999; 88(4):1225-40. PubMed ID: 10336132
[TBL] [Abstract][Full Text] [Related]
7. Purification, substrate specificity, and classification of tripeptidyl peptidase II.
Bålöw RM; Tomkinson B; Ragnarsson U; Zetterqvist O
J Biol Chem; 1986 Feb; 261(5):2409-17. PubMed ID: 3511062
[TBL] [Abstract][Full Text] [Related]
8. Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra.
Mauborgne A; Bourgoin S; Benoliel JJ; Hirsch M; Berthier JL; Hamon M; Cesselin F
J Pharmacol Exp Ther; 1987 Nov; 243(2):674-80. PubMed ID: 2445957
[TBL] [Abstract][Full Text] [Related]
9. Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain: microdialysis combined with a sequential multiple antigen radioimmunoassay.
Maidment NT; Siddall BJ; Rudolph VR; Erdelyi E; Evans CJ
Neuroscience; 1991; 45(1):81-93. PubMed ID: 1754070
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of neurotensin by rat brain synaptic membranes. Cleavage at the Pro10-Tyr11 bond by endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase.
Checler F; Emson PC; Vincent JP; Kitabgi P
J Neurochem; 1984 Nov; 43(5):1295-301. PubMed ID: 6387047
[TBL] [Abstract][Full Text] [Related]
11. Regional metabolism of Met-enkephalin and cholecystokinin on intact ratbrain slices: characterization of specific peptidases.
Konkoy CS; Davis TP
J Neurochem; 1995 Dec; 65(6):2773-82. PubMed ID: 7595577
[TBL] [Abstract][Full Text] [Related]
12. Characterization and inhibition of a cholecystokinin-inactivating serine peptidase.
Rose C; Vargas F; Facchinetti P; Bourgeat P; Bambal RB; Bishop PB; Chan SM; Moore AN; Ganellin CR; Schwartz JC
Nature; 1996 Apr; 380(6573):403-9. PubMed ID: 8602240
[TBL] [Abstract][Full Text] [Related]
13. The endogenous tripeptide Tyr-Gly-Gly as a possible metabolite of opioid peptides in rat brain: identification, regional distribution, effects of lesions and formation in depolarized slices.
Giros B; Llorens-Cortes C; Gros C; Schwartz JC
Peptides; 1986; 7(4):669-77. PubMed ID: 3532054
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor.
Chaillet P; Marçais-Collado H; Costentin J; Yi CC; De La Baume S; Schwartz JC
Eur J Pharmacol; 1983 Jan; 86(3-4):329-36. PubMed ID: 6572590
[TBL] [Abstract][Full Text] [Related]
15. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
Giros B; Gros C; Solhonne B; Schwartz JC
Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
[TBL] [Abstract][Full Text] [Related]
16. Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamus.
Kitabgi P; Dubuc I; Nouel D; Costentin J; Cuber JC; Fulcrand H; Doulut S; Rodriguez M; Martinez J
Neurosci Lett; 1992 Aug; 142(2):200-4. PubMed ID: 1454216
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of serine proteinase 2 from Bacillus intermedius 3-19.
Balaban NP; Mardanova AM; Sharipova MR; Gabdrakhmanova LA; Sokolova EA; Rudenskaya GN; Leshchinskaya IB
Biochemistry (Mosc); 2004 Apr; 69(4):420-6. PubMed ID: 15170378
[TBL] [Abstract][Full Text] [Related]
18. Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cord.
Bourgoin S; Le Bars D; Artaud F; Clot AM; Bouboutou R; Fournie-Zaluski MC; Roques BP; Hamon M; Cesselin F
J Pharmacol Exp Ther; 1986 Jul; 238(1):360-6. PubMed ID: 3459871
[TBL] [Abstract][Full Text] [Related]
19. Effect of peptidases on the ability of exogenous and endogenous neurokinins to produce neurokinin 1 receptor internalization in the rat spinal cord.
Marvizon JC; Wang X; Lao LJ; Song B
Br J Pharmacol; 2003 Dec; 140(8):1389-98. PubMed ID: 14623771
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]